Our client is a commercial-stage specialty pharmaceutical company dedicated to improving patient access to orphan medicines across Europe. Their mission is to ensure that patients with rare diseases receive innovative treatments, regardless of their location.
The company collaborates with research-based biopharmaceutical originators, offering end-to-end commercialization and distribution partnerships to unlock the full potential of orphan medicines in European markets. By acquiring, licensing, or distributing approved or late-stage medications, the company navigates the complexities and costs associated with bringing these treatments to diverse European countries.
Volker Geiße
vg@nik-executivesearch.com
Bayern
Remote - München